A 48-year-old woman with diabetic nephropathy (eGFR 22 mL/min) and a 35-year-old man with acute tumor lysis syndrome both present with serum potassium 7.2 mEq/L and peaked T waves. Which clinical feature best distinguishes the underlying mechanism of hyperkalemia in these two patients?

Explanation

## Hyperkalemia in Renal Failure vs. Tumor Lysis Syndrome ### Clinical Context **Diabetic nephropathy (chronic renal failure):** - Progressive loss of GFR - Hyperkalemia develops gradually due to impaired renal excretion - Other electrolyte abnormalities (hyperphosphatemia, hypocalcemia) develop over time **Tumor lysis syndrome (acute transcellular shift):** - Rapid release of intracellular contents (K⁺, phosphate, uric acid, nucleic acids) - Hyperkalemia is acute and due to massive transcellular shift - Hyperphosphatemia and hyperuricemia are hallmark features ### Best Discriminator: Serum Phosphate and Uric Acid **High-Yield:** The **constellation of markedly elevated phosphate and uric acid** is pathognomonic for tumor lysis syndrome and distinguishes it from chronic renal failure: | Feature | Diabetic Nephropathy | Tumor Lysis Syndrome | |---------|----------------------|---------------------| | **Serum Phosphate** | Elevated (chronic) | **Markedly elevated** (acute) | | **Serum Uric Acid** | Normal to mildly elevated | **Markedly elevated** (from purine breakdown) | | **Serum K⁺ rise** | Gradual (days to weeks) | **Acute** (hours) | | **LDH** | Normal | **Markedly elevated** | | **Mechanism** | Decreased excretion | Transcellular shift + cell lysis | ### Key Point **Key Point:** In tumor lysis syndrome, the **triad of hyperkalemia + hyperphosphatemia + hyperuricemia** is diagnostic. In chronic renal failure, phosphate and uric acid rise gradually and proportionally to declining GFR; acute, **disproportionate elevation** of phosphate and uric acid signals acute cell lysis. ### Clinical Pearl **Clinical Pearl:** Uric acid >20 mg/dL and phosphate >10 mg/dL in the setting of acute hyperkalemia strongly suggest tumor lysis syndrome. Measure LDH, uric acid, and phosphate in any patient with acute hyperkalemia to distinguish mechanism. [cite:Harrison 21e Ch 195, Ch 280]